Abstract
High neutrophil elastase (NE) activity in the sputum from cystic fibrosis (CF) patients is regarded as an important factor in CF lung pathophysiology. Therefore, a new therapeutic approach is aerosol delivery of antielastases such as secretory leukoprotease inhibitor (SLPI) to CF airways. We investigated the in vitro interactions of CF sputum samples (n=32) with recombinant native SLPI (rSLPI) and its partially oxidation-resistant variant (rSLPI-242; Grunenthal, Germany) in order to estimate their therapeutic potentials. We found that both rSLPI and rSLPI-242 dose-dependently inhibited NE activity in neutrophil-free supernatants from diluted CF sputum; addition of an oxidant resulted in superiority of rSLPI-242 over rSLPI. when fresh, neutrophil-rich CF sputum samples were incubated with rSLPI or rSLPI-242, inhibition of sputum NE activity by rSLPI-242 was significantly higher than inhibition by rSLPI; addition of an antioxidant improved the effect of rSLPI. Secretion induced from porcine tracheal submucosal glands by purified NE or by CF sputum supernatants was inhibited by rSLPI and rSLPI-242, resp., with superiority of rSLPI-242; addition of an antioxidant abrogated this difference, we conclude that either rSLPI or rSLPI-242 may efficiently inhibit NE activity and its effects in CF airways; the oxidation-resistant rSLPI-242 appears to be advantageous.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schuster, A., Hansen, G., Zubrod, C. et al. 297 INHIBITION OF NEUTROPHIL ELASTASE IN CYSTIC FIBROSIS SPUTUM BY NATIVE AND OXIDATION-RESISTANT SECRETORY LEUKOPROTEASE INHIBITOR. Pediatr Res 36, 52 (1994). https://doi.org/10.1203/00006450-199407000-00297
Issue Date:
DOI: https://doi.org/10.1203/00006450-199407000-00297